5th Latin American Congress of Clinical Research: Regional Perspectives and Future Trends
Venue: Sheraton Buenos Aires Hotel
|Event Date/Time: Nov 20, 2008||End Date/Time: Nov 21, 2008|
â€œTrends in Global Clinical Trials: The Role of the Emerging Marketsâ€
Ronald D. Fitzmartin, Immediate Past President, DIA Board of Directors
FDA guidelines on pharmacogenetics and pharmacogenomics.
Ethical and legal aspects for personal data protection and the informed consent in pharmacogenetic/ pharmacogenomic studies.
Industry-sponsored pharmacogenetic studies.
Future trends on the regulations in Latin America. Where are they going to?
Regulatory authorities from Peru, Mexico, Chile, Brazil, Argentina.
Regulatory framework for clinical trials in Latin America.
FDA requirements for conducting clinical trials in foreign countries. Update on new FDA requirements.
Inspections in Latin America - ANMAT.
Receiving an FDA inspection (round table with investigators â€“ Argentina, Chile and Brazil).
Pediatric clinical trials in Latin America.
International framework of guidelines and regulations.
Conducting clinical trials in Latin America. Industry/CRO experience (vaccines).
Challenges in running pediatric clinical trials. A PI perspective.
Guidelines for running pediatric clinical trials in Latin America.